ALTOB

ANALYTICA OPT JUN23 [ALTOB]

About ALTOB

Analytica Limited (ALT) is a Brisbane-based public company dedicated to the design, development and supply of Class I and II medical devices into the Australian and NZ market. The Company's lead product is the PeriCoach System - an e-health treatment system for women who suffer Stress Urinary Incontinence. This affects 1 in 3 women worldwide and is mostly caused by trauma to the pelvic floor muscles as a result of pregnancy, childbirth and menopause.

Buy Australian shares starting with ALTOB. Invest today with a CHESS-sponsored broker!

Sector

CEO

Mr Geoff Daly

Industry

Website

analyticamedical.com

Market Capitalisation

$5M

Price-earnings ratio

-2.00

Dividend yield

0.00%

High today

$0.00

Low today

$0.00

Open price

$0.00

52-week high

52-week low

Announcements

ALTOB FAQs

How much is one share of ANALYTICA OPT JUN23 [ALTOB]?

One share of ANALYTICA OPT JUN23 [ALTOB] is valued at $0.00.

What is the ticker symbol for ANALYTICA OPT JUN23 [ALTOB]?

The ticker symbol for ANALYTICA OPT JUN23 [ALTOB] is ALTOB.

How do I buy ALTOB shares in Australia?

To buy ALTOB stocks in Australia you'll need to open an account with a broker like Stake.
To do so follow these steps:

Sign up in minutes, all you need is some I.D.
Choose Stake AUS
Deposit directly into your Stake wallet and you're ready to invest in ALTOB

What is the 52-week high for ANALYTICA OPT JUN23 [ALTOB] stock?

The ANALYTICA OPT JUN23 [ALTOB] 52-week high stock price is $NaN.

What is the 52-week low for ANALYTICA OPT JUN23 [ALTOB] stock?

The ANALYTICA OPT JUN23 [ALTOB] 52-week low stock price is $NaN.

What is the market capitalisation of ANALYTICA OPT JUN23 [ALTOB] ALTOB?

As of 23/03/2023 ANALYTICA OPT JUN23 [ALTOB] has a market cap of $5M.

Related Stocks

This does not constitute financial advice. You should do your own research before making an investment decision. Past performance is not a reliable indication of future performance. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.